![Arthur Kirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur Kirsch
Directeur/Membre du Conseil chez
ATEA PHARMACEUTICALS, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Arthur S.
Kirsch is currently an Independent Director at Liquidia Technologies, Inc. since 2016, an Independent Director at Liquidia Corp.
since 2020, a Director at Anavasi Diagnostics since 2022, an Independent Non-Executive Director at Evommune, Inc. starting in 2025, and an Independent Director at Atea Pharmaceuticals, Inc. starting in 2025.
Former positions include President & Chief Executive Officer at Natwest Securities Corp.
from 1990 to 1993, Chairman at POZEN, Inc. from 2015 to 2016, Independent Chairman at Old API Wind-down Ltd. from 2016 to 2019, Independent Director at Immunomedics, Inc. from 2015 to 2016, Director at PhysioSonics, Inc., Independent Director at Kadmon Holdings, Inc. from 2019 to 2021, Executive Vice President & Head-Equity Division at Drexel Burnham Lambert, Inc. from 1979 to 1990, President at NatWest Securities Ltd. from 1990 to 1993, Executive Vice President & Head-Research at Vector Securities LLC from 1994 to 2004, and MD, Head-Healthcare Research & Capital Markets at Prudential Vector Healthcare Group from 1999 to 2001.
Education includes undergraduate studies at the University of Rhode Island and an MBA from Baruch College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,05 % | 16/06/2026 | 46 637 ( 0,05 % ) | 3 M $ | 31/05/2026 |
| 18/06/2026 | 45 710 ( 0,06 % ) | 213 466 $ | 31/05/2026 |
Postes actifs de Arthur Kirsch
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur/Membre du Conseil | 28/06/2020 |
| ATEA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 20/02/2025 |
| EVOMMUNE, INC. | Directeur/Membre du Conseil | 07/11/2025 |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur/Membre du Conseil | 13/12/2016 |
Anavasi Diagnostics
 Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Directeur/Membre du Conseil | 02/11/2022 |
Anciens postes connus de Arthur Kirsch
| Sociétés | Poste | Fin |
|---|---|---|
| KADMON HOLDINGS, INC. | Directeur/Membre du Conseil | 01/11/2021 |
| OLD API WIND-DOWN LTD. | Président | 30/05/2019 |
| IMMUNOMEDICS, INC. | Directeur/Membre du Conseil | 13/10/2016 |
| POZEN INC. | Président | 05/02/2016 |
| ░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Arthur Kirsch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
POZEN, Inc.
 POZEN, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops therapeutics for diseases | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
PhysioSonics, Inc.
 PhysioSonics, Inc. Medical DistributorsDistribution Services Develops neurological medical devices | Distribution Services |
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Discovers, develops and delivers transformative therapies for unmet medical needs | Health Technology |
Atea Pharmaceuticals, Inc.
 Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
Drexel Burnham Lambert, Inc.
 Drexel Burnham Lambert, Inc. Agricultural Commodities/MillingProcess Industries Manufactures chocolates and sugar candies. | Process Industries |
NatWest Securities Ltd.
 NatWest Securities Ltd. Investment Banks/BrokersFinance Security Brokers Dealers | Finance |
University of Rhode Island
 University of Rhode Island Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vector Securities LLC
 Vector Securities LLC Investment Banks/BrokersFinance Provides investment banking services | Finance |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Natwest Securities Corp. | |
Prudential Vector Healthcare Group
 Prudential Vector Healthcare Group Investment ManagersFinance Provides investment banking services | Finance |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Liquidia Corp.
 Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Anavasi Diagnostics
Anavasi Diagnostics Medical SpecialtiesHealth Technology Operates as a medical technology company that develops molecular diagnostic testing | Health Technology |
Choisissez Zonebourse 
